We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
The "SAFE" Drugs Act would gut short-drug compounding, and it's progressing in the Senate. We need to stop it.
The stakes have never been higher. If you're weighing the trip to Washington this September for CCH, here’s why it matters more than ever.
With an Aug. 1 ban fast approaching and no patient transition of care plan from FDA, we need enforcement discretion when it comes to compounded DTE.
.jpg)
It’s three nights of serious clinical instruction and CE for pharmacists and technicians, and this year it’s all about hormones.
Some quick news items from APC and the world of compounding pharmacy
.png?width=410&height=320&name=image-container%20(1).png)
.png?width=410&height=320&name=image-container%20(2).png)
.png?width=411&height=320&name=image-container%20(3).png)
.png?width=410&height=320&name=image-container%20(4).png)
.png)
.png?width=17&height=16&name=folder%20(1).png){kind=small}
%20Pharma-GS.png)
